SANUWAVE Health, Inc. (OTCMKTS:SNWV) – Equities research analysts at Zacks Investment Research dropped their FY2018 earnings per share estimates for SANUWAVE Health in a research note issued on Monday, April 9th. Zacks Investment Research analyst B. Marckx now forecasts that the company will post earnings per share of ($0.05) for the year, down from their previous forecast of ($0.02).
SANUWAVE Health (OTCMKTS:SNWV) last posted its quarterly earnings data on Thursday, March 29th. The company reported ($0.02) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.01) by ($0.01). The company had revenue of $0.32 million for the quarter, compared to analyst estimates of $0.25 million.
OTCMKTS SNWV opened at $0.54 on Thursday. SANUWAVE Health has a 12 month low of $0.08 and a 12 month high of $0.64.
About SANUWAVE Health
SANUWAVE Health, Inc is an acoustic pressure shock wave technology company using a system of noninvasive, high-energy, acoustic pressure shock waves for indications, such as regenerative medicine and other applications. The Company is focused on regenerative medicine utilizing noninvasive (extracorporeal), acoustic pressure shock waves to produce a biological response resulting in the body healing itself through the repair and regeneration of skin, musculoskeletal tissue and vascular structures.
Receive News & Ratings for SANUWAVE Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SANUWAVE Health and related companies with MarketBeat.com's FREE daily email newsletter.